Tag: Accelerated drug approvals

Top 10 Trends Driving Healthcare in 2018

ISPOR Announces Influential Topics in Health Economics and Outcomes Research   Lawrenceville, NJ, USA—February 6, 2018—ISPOR, the professional society for health economics and outcomes research (HEOR), announced today the release of its “Top 10 HEOR Trends” list that identifies the

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , , , , , , ,

ISPOR 21st ANNUAL INTERNATIONAL MEETING CONVENED KEY HEALTH CARE STAKEHOLDERS IN WASHINGTON, DC

Princeton, NJ—June 9, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting recently concluded in Washington, DC, USA. Government officials, health ministries, and global thought leaders in health economics and outcomes research (HEOR) from more than

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , , , , , ,

PLENARY 1 OF ISPOR 21ST ANNUAL INTERNATIONAL MEETING FOCUSES ON ISSUES SURROUNDING ACCELERATED DRUG APPROVALS

Washington, DC —May 23, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) opened its 21st Annual International Meeting this morning with the first plenary session, Accelerating Cures: Addressing Unmet Patient Need or Putting Patients at Risk?, in Washington, DC,

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , , , ,